CAR T Therapy for Glioblastoma: EGFR & IL-13Rα2 Trial
Glioblastoma Treatment: The Dawn of Personalized Immunotherapy and Beyond Despite decades of research, glioblastoma, the most aggressive form of brain cancer, remains a formidable challenge. But a wave of clinical trials, detailed in recent publications like the CBTRUS statistical report (Price et al., 2024) and a surge of studies focused on CAR T-cell therapies, are … Read more